Loading...
Keywords
Last Name
Institution

Connection

Matthew McLaughlin to Botulinum Toxins, Type A

This is a "connection" page, showing publications Matthew McLaughlin has written about Botulinum Toxins, Type A.

 
Connection Strength
 
 
 
1.589
 
  1. Sinn CN, Rinaldi RJ, McLaughlin MJ. Botulinum toxin type A outcomes in infants with refractory congenital muscular torticollis. J Pediatr Rehabil Med. 2023; 16(3):539-552.
    View in: PubMed
    Score: 0.877
  2. McLaughlin MJ, Fisher MT, Vadivelu S, Ramsey J, Ratnasingam D, McGhee E, Hartman K. A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19). J Pediatr Rehabil Med. 2020; 13(3):273-279.
    View in: PubMed
    Score: 0.712
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.